Dalziel; Sean

Patent Applications and Registrations

Patent applications and USPTO patent grants for Dalziel; Sean.The latest application filed is for "compositions, formulations and interleukin production and purification".

Company Profile

7.11.18

Dalziel; Sean - South San Francisco CA
Dalziel; Sean - Burlingame CA
Dalziel; Sean - San Francisco CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Compositions, formulations and interleukin production and purification Grant 11,160,869 - Maclean , et al. November 2, 2	2021-11-02
Compositions, Formulations And Interleukin Production And Purification App 20210154304 - Maclean; Derek ; et al.	2021-05-27
Crystalline Salts Of Peptide Epoxyketone Immunoproteasome Inhibitor App 20210032232 - Johnson; Henry ; et al.	2021-02-04
Process Of Preparing A Peptide Epoxyketone Immunoproteasome Inhibitor, And Precursors Thereof App 20200407334 - Johnson; Henry ; et al.	2020-12-31
Crystalline salts of peptide epoxyketone immunoproteasome inhibitor Grant 10,836,756 - Johnson , et al. November 17, 2	2020-11-17
Process of preparing a peptide epoxyketone immunoproteasome inhibitor, and precursors thereof Grant 10,781,192 - Johnson , et al. Sept	2020-09-22
Crystalline Salts Of Peptide Epoxyketone Immunoproteasome Inhibitor App 20190308961 - Johnson; Henry ; et al.	2019-10-10
Crystalline forms of an 8-azabicyclo[3.2.1]octane compound Grant 10,426,766 - Dalziel , et al. October 1, 2	2019-10-01
Process Of Preparing A Peptide Epoxyketone Immunoproteasome Inhibitor, And Precursors Thereof App 20190194155 - Johnson; Henry ; et al.	2019-06-27
Cyclodextrin complexation methods for formulating peptide proteasome inhibitors Grant 10,159,746 - Lewis , et al. Dec	2018-12-25
Crystalline Forms Of An 8-azabicyclo[3.2.1]octane Compound App 20180200246 - Dalziel; Sean ; et al.	2018-07-19
Crystalline forms of an 8-azabicyclo[3.2.1]octane compound Grant 9,949,963 - Dalziel , et al. April 24, 2	2018-04-24
Crystalline Forms Of An 8-azabicyclo[3.2.1]octane Compound App 20160287572 - Dalziel; Sean ; et al.	2016-10-06
Cyclodextrin Complexation Methods For Formulating Peptide Proteasome Inhibitors App 20150111838 - Lewis; Evan ; et al.	2015-04-23
Crystalline forms of an 8-azabicyclo[3.2.1]octane compound Grant 8,816,091 - Dalziel , et al. August 26, 2	2014-08-26
Crystalline Forms Of An 8-azabicyclo[3.2.1]octane Compound App 20140080856 - Dalziel; Sean ; et al.	2014-03-20
Cylodextrin Complexation Methods for Formulating Peptide Proteasome Inhibitors App 20130303482 - Lewis; Evan ; et al.	2013-11-14
Cylodextrin Complexation Methods for Formulating Peptide Proteasome Inhibitors App 20130303465 - Lewis; Evan ; et al.	2013-11-14
Benzimidazole-carboxamide compounds as 5-HT.sub.4 receptor agonists Grant 8,143,279 - McKinnell , et al. March 27, 2	2012-03-27
Crystalline Forms Of An 8-azabicyclo[3.2.1]octane Compound App 20110184008 - Dalziel; Sean ; et al.	2011-07-28
Crystalline forms of an 8-azabicyclo(3.2.1)octane compound Grant 7,943,772 - Dalziel , et al. May 17, 2	2011-05-17
8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists Grant 7,622,508 - Long , et al. November 24, 2	2009-11-24
Benzimidazole-carboxamide compounds as 5-ht4 receptor agonists App 20090209582 - McKinnell; Robert Murray ; et al.	2009-08-20
Crystalline forms of an 8-Azabicyclo(3.2.1)octane compound App 20080207676 - Dalziel; Sean ; et al.	2008-08-28
8-Azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists App 20070219278 - Long; Daniel D. ; et al.	2007-09-20

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.